<DOC>
	<DOCNO>NCT00962481</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability efficacy repeat inhalative dos Bimosiamose ozone induce sputum neutrophilia healthy subject .</brief_summary>
	<brief_title>Study Evaluate Effect Bimosiamose Ozone Induced Sputum Neutrophilia</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Able produce sputum normal sputum neutrophil level screen ( &lt; 65 % nonepithelial cell ) . Ozone responsive , define ≥ 20 % relative increase sputum neutrophil cell count 3 h ozone challenge . At screen FEV1 least 80 % predict . Smokers ( use tobacco product previous 3 month ) . Urine cotinine level measure screening subject . Smokers define subject report recent tobacco use and/or urine cotinine ≥ 500 ng/mL . Significant illness within two week prior dose ( e.g. , infection ) . Recent ( within last three year ) and/or recurrent history acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>